HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CTFA Requests Action On Cosmetic-Drugs in 1999 TABD Summits

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic, Toiletry and Fragrance Association is asking the TransAtlantic Business Dialogue to take action on an exemption of cosmetic-drugs and address the speed of approval of sunscreen ingredient labeling in its June and December 1999 summits. CTFA made the request in Nov. 30 draft comments following the last TABD meeting held in Charlotte N.C. Nov. 5-7.

You may also be interested in...



International Cosmetics Issues Warrant Greater FDA Involvement, CTFA Says

FDA should increase its participation in international regulatory forums involving cosmetics, the Cosmetic, Toiletry and Fragrance Association reiterates in Oct. 27 comments to the agency on CFSAN's three-year draft agenda on international priorities.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
UsernamePublicRestriction

Register

RS006080

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel